Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports
Published by Global Banking & Finance Review®
Posted on October 30, 2025
1 min readLast updated: January 21, 2026
Published by Global Banking & Finance Review®
Posted on October 30, 2025
1 min readLast updated: January 21, 2026
Novo Nordisk raises its bid for Metsera to outbid Pfizer, aiming to consolidate its position in the weight-loss medication market, as reported by Bloomberg.
(Reuters) -Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.
(Reporting by Sriparna Roy in Bengaluru; Editing by Mrigank Dhaniwala)
A bid is an offer made by an individual or company to purchase an asset or service at a specified price. In finance, bids are often used in auctions or competitive purchasing situations.
The pharmaceutical market refers to the industry involved in the research, development, production, and marketing of medications. It includes both prescription and over-the-counter drugs.
Weight-loss medications are drugs designed to help individuals lose weight by suppressing appetite, increasing feelings of fullness, or reducing absorption of calories. They are often prescribed alongside lifestyle changes.
Explore more articles in the Headlines category


